α7 nicotinic receptor full agonist reverse basolateral amygdala hyperactivity and attenuation of dopaminergic neuron activity in rats exposed to chronic mild stress

Eur Neuropsychopharmacol. 2019 Dec;29(12):1343-1353. doi: 10.1016/j.euroneuro.2019.09.009. Epub 2019 Oct 12.

Abstract

Neuroimaging and preclinical studies showing that nicotinic receptors (nAChR) may play a role in mood control has increased interest in targeting the cholinergic system for treatment of major depressive disorder. Indeed, modulation of nAChRs in the basolateral amygdala (BLA) are sufficient to produce an anti-immobility effect in the mouse tail suspension test. However, how α7 nAChR modulation impacts BLA neuronal activity in vivo as well as the downstream mechanisms involved in its mood-related effects are not understood. In this work, we used the unpredictable chronic mild stress (CMS) model to investigate the mechanisms underlying the antidepressant-like effect of an α7 nAChR full agonist on BLA-induced changes in dopaminergic neurotransmission. Male adult Sprague-Dawley rats were exposed to four weeks of CMS. Behavioral and electrophysiological experiments were performed within one week following stress. CMS exposure increased rats' immobility time in the forced swimming test, decreased the number of spontaneously active dopamine neurons in the ventral tegmental area and increased the firing rate of putative projection neurons in the BLA. Stress-induced behavioral and electrophysiological changes were reversed by a single systemic administration of PNU282987. In summary, our findings corroborate previous descriptions of a potential rapid antidepressant effect for the α7 nAChR full agonist. This effect appears to involve a mechanism distinct from those of classic antidepressants: normalization of BLA hyperactivity and, consequently, of DA hypofunction. These observations corroborate the role of α7 nAChR as a potential target for novel antidepressant drug development.

Keywords: Basolateral amygdala; Chronic mild stress; Dopamine; Electrophysiology; Ventral tegmental area; α7 nicotinic receptor.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Basolateral Nuclear Complex / drug effects*
  • Basolateral Nuclear Complex / metabolism
  • Benzamides / pharmacology
  • Benzamides / therapeutic use*
  • Bridged Bicyclo Compounds / pharmacology
  • Bridged Bicyclo Compounds / therapeutic use*
  • Chronic Disease
  • Dopaminergic Neurons / drug effects
  • Dopaminergic Neurons / metabolism
  • Hyperkinesis / drug therapy*
  • Hyperkinesis / metabolism
  • Hyperkinesis / psychology
  • Male
  • Nicotinic Agonists / pharmacology
  • Nicotinic Agonists / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Stress, Psychological / drug therapy*
  • Stress, Psychological / metabolism
  • Stress, Psychological / psychology
  • alpha7 Nicotinic Acetylcholine Receptor / agonists*

Substances

  • Benzamides
  • Bridged Bicyclo Compounds
  • Nicotinic Agonists
  • PNU-282987
  • alpha7 Nicotinic Acetylcholine Receptor